A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 40
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : FDG-PET
Long Form : 18F-fluorodeoxyglucose PET
No. Year Title Co-occurring Abbreviation
2020 First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma. PK
2020 Hybrid positron emission tomography imaging for initial staging of sinonasal tumors: Total lesion glycolysis as prognosticator of treatment response. CR, DM, PET, TLG
2020 On the conundrum of cognitive impairment due to depressive disorder in older patients. AD, Am-PET, CSF, DD, HC
2020 The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. CBS, PPAOS, PSP
2019 Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer's Disease Continuum. AD, CSF, HP, IPL, MCI, PET, SUVR
2019 Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease. PiB-PET
2019 Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders. AP, HD, PD
2019 Recent developments in penile cancer imaging. CT, SNB, SPECT
2018 Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET. GTV, LN, nonHSV, RCT
10  2017 Early functional network alterations in asymptomatic elders at risk for Alzheimer's disease. AD, FC
11  2017 Multimodal Fingerprints of Resting State Networks as assessed by Simultaneous Trimodal MR-PET-EEG Imaging. DMN, MRS
12  2017 Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease. AD, fMRI, NC, NEC, rs-fMRI, SUVR
13  2016 Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders. AD, ADNI, CMRgl, MCI, MRI, NC, PLD3
14  2016 Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis. ALS, ICA, PET, VOI
15  2016 Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares. AD, ADNI, MCI, MRI, PLS, RF, SVM
16  2016 Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. cHL, EVs, exRNA, miRNAs, SEC, STW
17  2016 The Neural Basis of Postural Instability Gait Disorder Subtype of Parkinson's Disease: A PET and fMRI Study. BA, FC, PIGD, TD
18  2015 Relationship between simultaneously acquired resting-state regional cerebral glucose metabolism and functional MRI: a PET/MR hybrid scanner study. DC, fALFF, GM, ReHo
19  2014 FDG-PET and amyloid-PET imaging: the diverging paths. ---
20  2014 Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography. AD, CMRglc, PET
21  2013 Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. CMRI, CSS, MDE
22  2013 Homonymous hemianopia in nonketotic hyperglycemia is an ictal phenomenon. ---
23  2012 Apathy in patients with Parkinson disease without dementia or depression: a PET study. AES, BA, LEDD, MADRS, MDRS, PD, UPDRS-III
24  2012 Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. PGRN
25  2011 Impact of FDG-PET/CT in the management of lymphoma. ---
26  2010 Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. BPF, VBM
27  2010 Cortical control of thermoregulatory sympathetic activation. ---
28  2010 Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex. MSI, TSC
29  2010 Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging. C-PET
30  2009 Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. CI, CT, DTC, WBS
31  2008 Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke. OECs, SDF-1alpha
32  2008 Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. GTV, PET-CT
33  2008 [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report]. ---
34  2007 PET-CT fusion in radiation management of patients with anorectal tumors. CT, CT-GTV, CT-PTV, OVs, PET-CT
35  2007 Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer. ProGRP
36  2005 Applications of PET in liver imaging. ---
37  2005 Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. MTLE, SPM
38  2003 Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids. ---
39  1998 Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. FMZ-PET
40  1995 The use of PET in evaluating patients with primary brain tumours: is it useful? ---